Home / Inspections / 1312298

FDA Inspection 1312298 — AstraZeneca Pharmaceuticals, LP

AstraZeneca Pharmaceuticals, LP — FEI 3010199915

The FDA completed an inspection of AstraZeneca Pharmaceuticals, LP on April 3, 2026 in Coppell, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 3, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Coppell, TX (United States)

Facility

Other inspections at this facility

  • 1047488 (NAI Mon Mar 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 998797 (OAI Mon Jan 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 963627 (OAI Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 954660 (NAI Fri Dec 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources